MAP3K5 and neoplasm: To trigger apoptosis in tumor cells, PEPE2 treatment likely disrupted the HSP90/Akt‐1/Ask‐1 pathway, as evidenced by the upregulation of ser83 phosphorylation and the upregulation of Thr845 phosphorylation of ASK‐1 in UBUC cells.